VBWG

70 related results for Vascular Biology in Clinical Practice © Vol. 6, No. 3


Core Curriculum

Vascular Dysfunction: Sequelae of Acute Hypertension

View/Download individual slides (84 Slides)

Core Curriculum

Myocardial Ischemia Redefined: Optimal Care in CAD

View/Download individual slides (90 Slides)

Core Curriculum

Targeting Insulin Resistance for Vascular Protection

View/Download individual slides (120 Slides)

Vascular Biology in Clinical Practice TM Vol. 7, No. 2

New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy

This monograph, New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy , is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 7, No. 1

ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection

This monograph, ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection , which is being offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Core Curriculum

Insulin Resistance and Cardiovascular Disease: New Perspectives From Vascular Biology

View/Download individual slides (94 Slides)

Core Curriculum

Improving Outcomes in Heart Failure: New Insights From Vascular Biology

View/Download individual slides (53 Slides)

TNT: New data on intensive lipid lowering in stable CAD patients

View/Download individual slides (16 Slides)

New data on optimal BP lowering in CAD patients: CAMELOT

The results of the Comparison of Amlodipine vs Enalapril to Limit Occurrence of Thrombosis (CAMELOT) study have recently been published.

Core Curriculum

Impact of vascular biology on cardiovascular disease, risk prevention, and treatment Section IV - Update: RAAS manipulation and cardiovascular risk--Hope for Peace?

The VBWG Core Curriculum 2004: Impact of vascular biology on cardiovascular disease, risk prevention, and treatment.

Vascular Biology in Clinical Practice © Vol. 6, No. 2

High-dose statins and early benefit in ACS: Role of inflammation

This monograph, High-dose statins and early benefit in ACS: Role of inflammation , is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 6, No. 1

How low should LDL-C level be? New data, new direction

This monograph, How low should LDL-C level be? New data, new direction, offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Core Curriculum

Impact of vascular biology on cardiovascular disease, risk prevention, and treatment Section V: Multiple risk and CV disease prevention

The VBWG Core Curriculum 2004: Impact of vascular biology on cardiovascular disease, risk prevention, and treatment.

Core Curriculum

Impact of vascular biology on cardiovascular disease, risk prevention, and treatment Section IV: RAAS manipulation and cardiovascular risk

The VBWG Core Curriculum 2004: Impact of vascular biology on cardiovascular disease, risk prevention, and treatment.

Core Curriculum

Impact of vascular biology on cardiovascular disease, risk prevention, and treatment Section III: Heart failure: The new vascular biology imperative to blunt progression

The VBWG Core Curriculum 2004: Impact of vascular biology on cardiovascular disease, risk prevention, and treatment.

Core Curriculum

Impact of vascular biology on cardiovascular disease, risk prevention, and treatment Section II: Blunting the atherosclerotic process: The case for aggressive lipid management

The VBWG Core Curriculum 2004: Impact of vascular biology on cardiovascular disease, risk prevention, and treatment.

Core Curriculum

Impact of vascular biology on cardiovascular disease, risk prevention, and treatment Section I: Atrial fibrillation, anticoagulation, and stroke prevention

The VBWG Core Curriculum 2004: Impact of vascular biology on cardiovascular disease, risk prevention, and treatment.

Core Curriculum

Impact of vascular biology in treatment of cardiovascular disease Section V: Atrial fibrillation, anticoagulation, and stroke prevention

The VBWG Core Curriculum 2003 slide lecture compendium Impact of vascular biology in treatment of cardiovascular disease , provides updates on new science and mechanisms of disease, plus implications of recent clinical trials.

Vascular Biology in Clinical Practice © Vol. 5, No. 3

Atrial fibrillation and thromboembolism: Implications for stroke prevention

This monograph, Atrial fibrillation and thromboembolism: Implications for stroke prevention , is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

The CHARM program: Enhancement of RAAS manipulation in heart failure

Clinical trials have demonstrated the benefits of angiotensin-converting enzyme (ACE) inhibitors 1 and ß-blockers 2-4 in patients with chronic heart failure (HF) and reduced left ventricular ejection fraction (LVEF).

Vascular Biology in Clinical Practice © Vol. 5, No. 2

Managing lipids in patients with diabetes: New evidence from vascular biology and clinical trials

This monograph, Managing lipids in patients with diabetes: New evidence from vascular biology and clinical trials , is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 5, No. 1

New strategies for global risk reduction: Focus on lipids and blood pressure

This monograph, New strategies for global risk reduction: Focus on lipids and blood pressure, is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

Core Curriculum

Impact of vascular biology in treatment of cardiovascular disease Section IV: Antithrombotic interventions in acute coronary syndromes

The VBWG Core Curriculum 2003 slide lecture compendium Impact of vascular biology in treatment of cardiovascular disease , provides updates on new science and mechanisms of disease, plus implications of recent clinical trials.

Core Curriculum

Impact of vascular biology in treatment of cardiovascular disease Section III: Neurohormonal strategies in the failing heart

The VBWG Core Curriculum 2003 slide lecture compendium Impact of vascular biology in treatment of cardiovascular disease , provides updates on new science and mechanisms of disease, plus implications of recent clinical trials.

Core Curriculum

Impact of vascular biology in treatment of cardiovascular disease Section II: Lipid management

The VBWG Core Curriculum 2003 slide lecture compendium, Impact of vascular biology in treatment of cardiovascular disease , provides updates on new science and mechanisms of disease, plus implications of recent clinical trials.

Core Curriculum

Impact of vascular biology in treatment of cardiovascular disease Section I: RAAS manipulation

The VBWG Core Curriculum 2003 slide lecture compendium, Impact of vascular biology in treatment of cardiovascular disease , provides updates on new science and mechanisms of disease, plus implications of recent clinical trials.

Vascular Biology in Clinical Practice © Vol. 4, No. 6

Prevention of stroke and cognitive dysfunction

This monograph, Prevention of stroke and cognitive dysfunction , is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

Cardiovascular considerations in treating erectile dysfunction

Impact of vascular biology in treatment of cardiovascular disease

This slide presentation covers basic science and clinical advances in treatment of erectile dysfunction, with emphasis on the cardiovascular patient.

Vascular Biology in Clinical Practice © Vol. 4, No. 5

The potential role of beta-blockade in blunting the progression of atherosclerosis

This monograph, The potential role of beta-blockade in blunting the progression of atherosclerosis , is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

Decrease in PAI-1 antigen is greater with ACE inhibition

Plasminogen activator inhibitor-1 (PAI-1) is a known risk factor for cardiovascular (CV) disease and myocardial infarction (MI).

Vascular Biology in Clinical Practice © Vol. 4, No. 4

Anticoagulant therapy in the PCI patient

This monograph, Anticoagulant therapy in the PCI patient , is intended to explore the role of anticoagulant therapy in patients scheduled for percutaneous coronary intervention, particularly as it is evolving in regard to other components of antithrombotic therapy (i.

Vascular Biology in Clinical Practice © Vol. 4, No. 3

Peri-interventional care: Rationale for ACE manipulation

This monograph, Peri-interventional care: Rationale for ACE manipulation , is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

HOPE: Effect of long-term therapy with ACE inhibition in high-risk women

Cardiovascular (CV) disease is currently the leading cause of death and the main hospital diagnosis in postmenopausal women.

Vascular Biology in Clinical Practice © Vol. 4, No. 2

Beta-blocker therapy in heart failure: The new vascular biology imperative to blunt progression

This monograph, Beta-blocker therapy in heart failure: The new vascular biology imperative to blunt progression , is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 4, No. 1

LDL at the vascular wall: New insights, new relevance

This monograph, LDL at the vascular wall: New insights, new relevance , is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

Core Curriculum

Impact of vascular biology in treatment of cardiovascular disease Section IV: Antithrombotic interventions in acute coronary syndromes

The VBWG Core Curriculum 2002 slide lecture program, Impact of vascular biology in treatment of cardiovascular disease, covers basic science and clinical advances in vascular biology in a spectrum of disorders.

Preventing stroke with ACE inhibition

Each year, approximately 750,000 Americans suffer a first or recurrent stroke.

Core Curriculum

Impact of vascular biology in treatment of cardiovascular disease Section III: Neurohormonal strategies in heart failure

The VBWG Core Curriculum 2002 slide lecture program, Impact of vascular biology in treatment of cardiovascular disease, covers basic science and clinical advances in vascular biology in a spectrum of disorders.

Core Curriculum

Impact of vascular biology in treatment of cardiovascular disease Section II: Lipid management

The VBWG Core Curriculum 2002 slide lecture program, Impact of vascular biology in treatment of cardiovascular disease, covers basic science and clinical advances in vascular biology in a spectrum of disorders.

Core Curriculum

Impact of vascular biology in treatment of cardiovascular disease Section I: RAS manipulation

The VBWG Core Curriculum 2002 slide lecture program, Impact of vascular biology in treatment of cardiovascular disease, covers basic science and clinical advances in vascular biology in a spectrum of disorders.

Curriculum Update # 7

Managing renal disease for risk reduction: The expanding role of ACE inhibition

Chronic renal disease is a problem of increasing magnitude in the United States.

Vascular Biology in Clinical Practice © Vol. 3, No. 3

Lipids in the post-intervention continuum of care: New challenges and strategies in risk management

This monograph is offered as part of a series of educational programs published under the auspices of the VBWG, with continuing medical education credit provided by the University of Florida College of Medicine.

Curriculum Update # 6

Managing lipids for risk reduction: Focus on the new National Cholesterol Education Program guidelines

This Curriculum Update presents new perspectives on cholesterol management as suggested by the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III or ATP III).

Supplement to The American Journal of Cardiology October 18, 2001 vol. 88 (8A)

A Symposium: Interventions in cardiology: Focus on lipid management in acute and long-term settings

Exciting new data have emerged on the relative roles of medical therapy and percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS).

Vascular Biology in Clinical Practice © Vol. 3, No. 2

New insights into the antiatherosclerotic potential of ACE inhibition

This monograph, New insights into the antiatherosclerotic potential of ACE inhibition is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 3, No. 1

Cardiovascular risk reduction in the diabetic patient

This monograph, Cardiovascular risk reduction in the diabetic patient , is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

SECURE: ACE inhibition retards the progression of atherosclerosis

Final results of the Study to Evaluate Carotid Ultrasound changes with Ramipril and vitamin E (SECURE) have been published and confirm that treatment with ramipril 10 mg slows the progression of atherosclerosis, while treatment with vitamin E has no apparent effect.

Core Curriculum

Vascular biology for clinical practice: From basic concepts to mainstream medicine

Physicians who participated at recent Vascular Biology Working Group meetings have provided the direction for the development of these materials.

Vascular Biology in Clinical Practice © Vol. 2, No. 3

Diabetes and cardiovascular disease: The emerging role of the endothelium and implications for treatment

This monograph Diabetes and cardiovascular disease: The emerging role of the endothelium and implications for treatment.

Vascular Biology in Clinical Practice © Vol. 2, No. 2

RAS, lipids, and inflammation: New insights for therapeutic intervention

This monograph RAS, lipids, and inflammation: New insights for therapeutic intervention is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

Curriculum Update #4

Bradykinin and angiotensin-(1-7): Emerging allies in vascular function

The role of endothelial function in cardiovascular health provides an important conceptual framework for development of risk reduction strategies.

Vascular Biology in Clinical Practice © Vol. 2, No. 1

Bradykinin and angiotensin-(1-7): Emerging allies in vascular functioning

This monograph Bradykinin and Angiotensin-(1-7): Emerging allies in vascular functioning is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

Core Curriculum

The endothelium: New insights into the origins and treatment of CAD

Participants at recent Vascular Biology Working Group meetings have reviewed and provided significant direction in the development of this slide/lecture program entitled The endothelium: New insights into the origins and treatment of CAD.

Angiotensin-(1-7): New insights into the benefits of tissue ACE inhibition

Emerging new data are expanding our understanding of the renin-angiotensin system (RAS).

Angiotension type 1 receptor blockade versus ACE inhibition in the treatment of heart failure: Results of 3 clinical trials

Angiotension-converting enzyme (ACE) inhibitors are of critical importance for the treatment of patients with heart failure.

Curriculum Update #3

Clinical Trials Update: Tissue ACE inhibition offers new hope for treating cardiovascular disease

This Curriculum Update highlights important recent trials of tissue ACE inhibition in patients with cardiovascular disease and preserved left ventricular function.

Vascular Biology in Clinical Practice © Vol. 1, No. 4

Clinical trials update: Tissue ACE inhibition offers new hope for treating cardiovascular disease

Advances in vascular biology bring physicians the opportunity to apply new concepts in the treatment of patients with cardiovascular disease.

Data and Commentary: The BANFF Study

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease

J Am Coll Cardiol.

Data and Commentary:The HOPE Study

Effects of angiotensin-converting enzyme inhibition on cardiovascular events in high-risk patients

The Heart Outcomes Prevention Evaluation Study Investigators.

Curriculum Update #2

From hypertension to LVH and heart failure

This new program focuses on an area in which our understanding of vascular biology may have had the most profound impact on clinical practice to date.

HOPE: New validation for the importance of tissue ACE inhibition

The results of the recently published HOPE (Heart Outcomes Prevention Evaluation) study provide powerful confirmation of the clinical benefits of tissue angiotensin-converting enzyme (ACE) inhibition, now strikingly demonstrated in patients at high risk for cardiovascular events.

Vascular Biology in Clinical Practice

The vascular endothelium and CAD: New target considerations in treating the cardiovascular dysmetabolic syndrome

This discourse is based on the proceedings of a national faculty meeting of the Vascular Biology Working Group held in Orlando earlier this year that explored the clustering of metabolic abnormalities associated with what previously has been recognized by many as "syndrome X.

Vascular Biology in Clinical Practice © Vol. 1, No. 3

From hypertension to LVH and heart failure

Participants at recent Vascular Biology Working Group meetings have reviewed and provided significant direction in the development of this slide/lecture program entitled The endothelium: New insights into the origins and treatment of CAD.

The vascular endothelium and CAD: New target considerations in treating the cardiovascular dysmetabolic syndrome

The attached slide materials represent the seventh in a series of slide/lecture programs that focus on what continues to be one of the most exciting new fields of emerging data: The endothelium and its role in cardiovascular health and disease.

Vascular Biology in Clinical Practice © Vol. 1, No. 2

Overview of clinical trials to improve endothelial function

Fundamental views on the progression of cardiovascular disease are evolving toward a clearer understanding that the endothelium plays a central role in health and disease.

New data on the anti-ischemic effects of ACE inhibition

During the past decade, results from a number of clinical trials have revolutionized the way clinicians treat CHD and CAD.

Vascular Biology in Clinical Practice © Vol. 1, No. 1

The endothelium: Redefining the origins of cardiovascular disease

This CME monograph is the first in a series of educational programs aimed at taking the mystery out of vascular biology and making it relevant to patient care.

Focus: Lipids and the Endothelium

The Endothelium: Impact on CAD treatment strategies

These slide materials represent the third in a series of slide/lecture programs that focus on what continues to be one of the most exciting new fields of emerging data: The endothelium and its role in cardiovascular health and disease.